Jason Haas
Stock Analyst at Wells Fargo
(3.72)
# 694
Out of 4,784 analysts
63
Total ratings
61.11%
Success rate
4.28%
Average return
Main Sectors:
Stocks Rated by Jason Haas
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CTAS Cintas | Maintains: Underweight | $184 → $196 | $203.61 | -3.74% | 4 | Mar 27, 2025 | |
FDS FactSet Research Systems | Downgrades: Underweight | $450 → $402 | $446.76 | -10.02% | 5 | Mar 21, 2025 | |
VRSK Verisk Analytics | Maintains: Overweight | $325 → $321 | $294.23 | +9.10% | 3 | Feb 27, 2025 | |
CSGP CoStar Group | Maintains: Underweight | $65 → $63 | $79.58 | -20.83% | 1 | Feb 19, 2025 | |
SPGI S&P Global | Maintains: Overweight | $617 → $633 | $506.89 | +24.88% | 4 | Feb 12, 2025 | |
ECL Ecolab | Maintains: Overweight | $295 → $313 | $251.61 | +24.40% | 3 | Feb 12, 2025 | |
TRI Thomson Reuters | Maintains: Equal-Weight | $165 → $177 | $171.89 | +2.97% | 1 | Feb 7, 2025 | |
FICO Fair Isaac | Maintains: Overweight | $2,650 → $2,600 | $1,823.94 | +42.55% | 4 | Feb 5, 2025 | |
EFX Equifax | Maintains: Overweight | $321 → $313 | $241.06 | +29.84% | 5 | Feb 3, 2025 | |
BOOT Boot Barn Holdings | Maintains: Buy | $187 → $192 | $103.07 | +86.28% | 4 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $135 → $126 | $82.90 | +51.99% | 4 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $470 → $460 | $421.59 | +9.11% | 4 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $53.46 | +8.49% | 4 | Dec 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $130 | $111.56 | +16.53% | 6 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $62 | $55.49 | +11.73% | 3 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $570 → $600 | $574.18 | +4.50% | 2 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $510 → $550 | $463.74 | +18.60% | 2 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $125 → $149 | $160.59 | -7.22% | 2 | Mar 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $230 | $75.44 | +204.88% | 2 | Aug 31, 2023 |
Cintas
Mar 27, 2025
Maintains: Underweight
Price Target: $184 → $196
Current: $203.61
Upside: -3.74%
FactSet Research Systems
Mar 21, 2025
Downgrades: Underweight
Price Target: $450 → $402
Current: $446.76
Upside: -10.02%
Verisk Analytics
Feb 27, 2025
Maintains: Overweight
Price Target: $325 → $321
Current: $294.23
Upside: +9.10%
CoStar Group
Feb 19, 2025
Maintains: Underweight
Price Target: $65 → $63
Current: $79.58
Upside: -20.83%
S&P Global
Feb 12, 2025
Maintains: Overweight
Price Target: $617 → $633
Current: $506.89
Upside: +24.88%
Ecolab
Feb 12, 2025
Maintains: Overweight
Price Target: $295 → $313
Current: $251.61
Upside: +24.40%
Thomson Reuters
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $165 → $177
Current: $171.89
Upside: +2.97%
Fair Isaac
Feb 5, 2025
Maintains: Overweight
Price Target: $2,650 → $2,600
Current: $1,823.94
Upside: +42.55%
Equifax
Feb 3, 2025
Maintains: Overweight
Price Target: $321 → $313
Current: $241.06
Upside: +29.84%
Boot Barn Holdings
Jan 15, 2025
Maintains: Buy
Price Target: $187 → $192
Current: $103.07
Upside: +86.28%
Jan 10, 2025
Maintains: Overweight
Price Target: $135 → $126
Current: $82.90
Upside: +51.99%
Jan 10, 2025
Maintains: Underweight
Price Target: $470 → $460
Current: $421.59
Upside: +9.11%
Dec 16, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $53.46
Upside: +8.49%
Dec 11, 2024
Maintains: Buy
Price Target: $115 → $130
Current: $111.56
Upside: +16.53%
Nov 6, 2024
Maintains: Overweight
Price Target: $56 → $62
Current: $55.49
Upside: +11.73%
Oct 11, 2024
Maintains: Equal-Weight
Price Target: $570 → $600
Current: $574.18
Upside: +4.50%
Oct 9, 2024
Maintains: Overweight
Price Target: $510 → $550
Current: $463.74
Upside: +18.60%
Mar 21, 2024
Maintains: Neutral
Price Target: $125 → $149
Current: $160.59
Upside: -7.22%
Aug 31, 2023
Maintains: Buy
Price Target: $242 → $230
Current: $75.44
Upside: +204.88%